Progressive pseudorheumatoid dysplasia with new-found gene mutation of Wntl inducible signaling pathway protein 3
- PMID: 30200995
- PMCID: PMC6131911
- DOI: 10.1186/s12969-018-0272-7
Progressive pseudorheumatoid dysplasia with new-found gene mutation of Wntl inducible signaling pathway protein 3
Abstract
Background: As one kind of osteochondrodysplasia, progressive pseudorheumatoid dysplasia (PPD) is also known as spondyloepiphyseal dysplasia tarda with progressive arthropathy or arthropathy progressive pseudorheumatoid of childhood. PPD is a very rare disease, especially in China, and has an estimated prevalence of 1/1000000 due to lacking definite prevalence survey. It is an autosomal recessive disorder caused by gene mutation of Wntl inducible signaling pathway protein 3 (WISP3). Its basic pathological change is persistent degeneration and loss of articular cartilage in multiple joints. Its clinical appearances include bone enlargement, platyspondyly, irregular endplate, secondary osteoarthritis, extensive osteoporosis, joint rigidity and function loss. Clinical diagnosis of PPD is made based on clinical appearance and imaging examinations, whereas its definite diagnosis depends on gene sequencing. PPD has no severe effect on life span, but causes high disability rate and very poor prognosis. There are only case reports with limited information in China.
Case presentation: One female patient was diagnosed as PPD and secondary osteoarthritis. She had typical clinical appearance and imaging examinations, and received individualized therapeutic regimens. She had a gene mutation (c.72delT, p.T24TfsX4) of WISP3. This gene mutation has not been reported by previous literatures and included in Single Nucleotide Polymorphism Database.
Conclusions: As the first time, this paper reported a patient with PPD caused by new-found gene mutation (c.72delT, p.T24TfsX4) of WISP3.
Keywords: Progressive pseudorheumatoid dysplasia; Wntl inducible signaling pathway protein 3.
Conflict of interest statement
Ethics approval and consent to participate
The study protocol was approved by Ethics Committee of Hainan Branch of Chinese People’s Liberation Army General Hospital (Sanya, China). This participant provided written informed consent to be included in the study.
Consent for publication
Written consent for publication was obtained from this patient.
Competing interests
The authors declare that they have no conflict of interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
Early severe scoliosis in a patient with atypical progressive pseudorheumatoid dysplasia (PPD): Identification of two WISP3 mutations, one previously unreported.Am J Med Genet A. 2016 Jun;170(6):1595-9. doi: 10.1002/ajmg.a.37619. Epub 2016 Mar 17. Am J Med Genet A. 2016. PMID: 26991965
-
Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia.Mol Med Rep. 2015 Jul;12(1):419-25. doi: 10.3892/mmr.2015.3430. Epub 2015 Mar 4. Mol Med Rep. 2015. PMID: 25738435
-
[Clinical diagnosis and WISP3 gene mutation analysis for progressive pseudorheumatoid dysplasia].Zhonghua Er Ke Za Zhi. 2010 Mar;48(3):194-8. Zhonghua Er Ke Za Zhi. 2010. PMID: 20426955 Chinese.
-
Progressive pseudorheumatoid dysplasia: a rare childhood disease.Rheumatol Int. 2019 Mar;39(3):441-452. doi: 10.1007/s00296-018-4170-6. Epub 2018 Oct 16. Rheumatol Int. 2019. PMID: 30327864 Review.
-
The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals.Am J Med Genet C Semin Med Genet. 2012 Aug 15;160C(3):217-29. doi: 10.1002/ajmg.c.31333. Epub 2012 Jul 12. Am J Med Genet C Semin Med Genet. 2012. PMID: 22791401 Review.
Cited by
-
A retrospective study of nine patients with progressive pseudorheumatoid dysplasia: to explore early diagnosis and further treatment.Clin Rheumatol. 2022 Mar;41(3):877-888. doi: 10.1007/s10067-021-05959-2. Epub 2021 Oct 21. Clin Rheumatol. 2022. PMID: 34674084
-
Unique mutation spectrum of progressive pseudorheumatoid dysplasia in the Chinese population: a retrospective genotype-phenotype analysis of 105 patients.World J Pediatr. 2023 Jul;19(7):674-686. doi: 10.1007/s12519-022-00674-7. Epub 2023 Jan 9. World J Pediatr. 2023. PMID: 36622578 Free PMC article.
-
Progressive pseudorheumatoid dysplasia involving a novel CCN6 mutation: a case report.Front Immunol. 2024 Oct 30;15:1445420. doi: 10.3389/fimmu.2024.1445420. eCollection 2024. Front Immunol. 2024. PMID: 39539552 Free PMC article.
References
-
- Garcia Segarra N, Mittaz L, Campos-Xavier AB, Bartels CF, Tuysuz B, Alanay Y, et al. The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals. Am J Med Genet C Semin Med Genet. 2012;160:217–229. doi: 10.1002/ajmg.c.31333. - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials